MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, MCRB made $351K in revenue. $8,204K in net income. Net profit margin of 2337.32%.

Income Overview

Revenue
$351K
Net Income
$8,204K
Net Profit Margin
2337.32%
EPS
$0.94
Unit: Thousand (K) dollars
Revenue Breakdown
    • Grant revenue

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
Total revenue
351 -
Research and development expenses
12,616 12,939
General and administrative expenses
9,476 10,253
Manufacturing services
736 1,689
Total operating expenses
22,828 24,881
Interest expense
-0
Loss from operations
-22,477 -24,881
Gain on sale of vowst business
27,222 185
Interest income
618 546
Other income (expense)
2,841 4,295
Total other income (expense), net
30,681 5,026
Net income (loss) from continuing operations
8,204 -19,855
Net income from discontinued operations, net of tax
0 0
Net income (loss)
8,204 -19,855
Net loss per share attributable to common stockholders - basic
0.94 -2.27
Net loss per share attributable to common stockholders - diluted
0.94 -2.27
Weighted average number of shares outstanding, diluted
8,771,519 8,743,733
Weighted-average shares outstanding - basic
8,758,692 8,743,733
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Other income(expense)$2,841K Interest income$618K Gain on sale of vowstbusiness$27,222K Total other income(expense), net$30,681K Grant revenue$351K Net income (loss)from continuing...$8,204K Loss from operations-$22,477K Total revenue$351K Net income (loss)$8,204K Total operatingexpenses$22,828K Manufacturing services$736K General andadministrative expenses$9,476K Research and developmentexpenses$12,616K

Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics, Inc. (MCRB)